According to the latest market report published by Credence Research, Inc. “Heart Valve Devices Market – Growth, Future Prospects, and Competitive Analysis, 2017 – 2025,” the global heart valve devices market was valued at US$ 4,945 Mn in 2016, and is expected to reach US$ 13,377.9 Mn by 2025, expanding at a CAGR of 10.6% from 2017 to 2025.
Heart valve devices are basically use to treat the blockage of heart. Heart valve surgery or other surgical procedures are commonly used to repair or replace valve in the heart. This procedure improves survival rate and quality of life of the patient. Rising geriatric population, increase in prevalent population with heart valve disease and demand for novel and less invasive technology are significant factors contributing to the growth of heart valve devices market. With increase in investment in R&D and constant improvement in technology by the companies and their market expansion through strategic merger and acquisition further boast the growth of heart valve devices market.
Browse the full report Heart Valve Devices Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 at https://www.credenceresearch.com/report/heart-valve-devices-market
The global heart valve devices market is segmented by procedure type into heart valve repair and heart valve replacement. Heart valve repair is further segmented into surgical heart valve repair devices, percutaneous balloon valvuloplasty devices and transcatheter heart valve repair devices. Transcatheter heart valve is fast growing market due to preference for less invasive surgeries. Heart valve replacement is segmented by type into mechanical valves, tissue/bioprosthetic valves and transcatheter heart valves/ percutaneous heart valves. Mechanical valve replacement dominates the heart valve device market, due it high durability and observed significant improvement in survival rates in patient. It is further segmented into position by mitral valve replacement devices, aortic valve replacement devices and other position heart valve replacement devices. Most of the replacement take place for mitral and aortic damaged valves.
As of the current market scenario, North America dominates the global heart valve devices market followed by Europe. Every year around 5 million Americans are diagnosed with moderate or severe heart valve disease. Thus upsurge in cardiovascular diseases, demand for less invasive and novel technology are the main growth factors for heart valve devices market in North America. Asia Pacific is the fastest growing heart valve devices market in the forecast period. The key factors contributing to growth of Asia Pacific heart valve devices market are rise in prevalence of heart valve disease, increase in disposable income and improvement in healthcare infrastructure.
Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year. Further cross-sectional presented in terms of procedure type and constituent country level markets is also included in this section.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global heart valve devices market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global heart valve devices market. This report concludes with company profiles section that highlights major information about the key players engaged in the global heart valve devices market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.
Market Competition Assessment:
Key players in the global heart valve devices market are Abbott Laboratories, Boston Scientific Corporation, Cryolife, Inc., Edwards Lifesciences LLC, On-X Life Technologies, Inc., LivaNova, Plc., Medtronic, Plc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., Neovasc, Inc., Sorin Group, St. Jude Medical, Inc., TTK Healthcare Ltd and others.
Key Market Movements:
– Around 5 million American suffer from heart valve disease every year. Heart disease is considered as one of the leading cause of mortality. Thus substantial rise in burden of heart valve disease is the major growth driver for the heart valve device market.
– Minimally invasive and percutaneous heart valve technologies availability, wide array of surgical procedure, advances in heart valve therapies has revolutionized the traditional ways of treatment of valvular disease
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Heart Valve Devices Market Portraiture
2.1.1. Global Heart Valve Devices Market, by Procedure Type, 2016
2.1.2. Global Heart Valve Devices Market, by Geography, 2016
Chapter 3. Heart Valve Devices Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016
Company Name: Credence Research, Inc
Contact Person: Chris Smith, Global Sales Manager
Email: Send Email
Address:105 N 1st ST #429, SAN JOSE, CA 95103 US
City: SAN JOSE
Country: United States